Our group previously investigated the expression of MAGE-A10 and -A11 in breast cancers and showed that they were tumor-specific antigens and that MAGE-A11 expression was a prognostic factor for a poor patient outcome (26). This evidence concerns the gene MAGEA10 and neoplasm.